Resolutions of the Annual Shareholders' Meeting of Sartorius AG

At today’s Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved all board proposals by a large majority. Thus, the Annual Shareholders' Meeting passed the resolution to pay dividends of 0.96 euro per preference share (previous year: 0.82 euro) and 0.94 euro per ordinary share (previous year: 0.80 euro). Accordingly, the total amount of dividends to be paid out will rise 17.3% to 16.2 million euros from a year earlier.

The Annual Shareholders' Meeting granted discharge to the Supervisory Board and to the Executive Board by a considerable majority. On the whole, some 350 share owners representing over 95% of the voting share capital attended this year's Annual Shareholders' Meeting.

This is a translation of the original German-language press release. Sartorius (FWB:SRT) shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

Presentation by CEO Dr. J. Kreuzburg at the 2013 Annual Shareholders' Meeting

You will find a presentation held by Dr. Joachim Kreuzburg at the 2013 Annual Shareholders’ Meeting and further information at:

http://www.sartorius.de/de/konzern/investor-relations/sartorius-ag/hauptversammlung/2013/

Current Image Files:

Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG:

www.sartorius.com/fileadmin/media/global/company/joachim_kreuzburg_1.jpg

Sartorius products used in the manufacture of medications:

www.sartorius.com/fileadmin/media/global/company/pr_20120419_bioprocess_solutions.jpg

Sartorius products used in laboratory research:

www.sartorius.com/fileadmin/media/global/company/pr_20120419_lab_products_services.jpg

Upcoming Financial Dates

April 23, 2013 Publication of first-quarter figures (Jan. – March 2013)

July 23, 2013 Publication of first-half figures (Jan. – June 2013)

October 21, 2013 Publication of nine-month figures (January to September 2013)

A Profile of Sartorius

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of Bioprocess Solutions, Lab Products & Services and Industrial Weighing. In 2012, the technology group earned sales revenue of 845.7 million euros. Founded in 1870, the Goettingen-based company currently employs around 5,500 persons. The major areas of activity of its Bioprocess Solutions segment cover filtration, fluid management, fermentation, cell cultivation and purification, and focus on production processes in the biopharmaceutical industry. The Lab Products & Services segment primarily manufactures laboratory instruments and consumables. Industrial Weighing concentrates on weighing, monitoring and control applications in the manufacturing processes of the food, chemical and pharma sectors. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.